The FDA has granted a breakthrough device designation for an artificial intelligence (AI) pattern recognition software being developed by Bayer and Merck & Co. in New Jersey that can identify signs of chronic thromboembolic pulmonary hypertension (CTEPH)—a rare form of hypertension—in CT pulmonary angiography (CTPA) scans, according to a Dec. 3 press release.

Cryoablation may be an effective treatment method for women with low-risk breast cancers, according to research presented at RSNA 2018 in Chicago.

Authors of a recent study reported improved survival in patients with aggressive non-Hodgkin lymphoma (HL) whose first-line therapy was guided by PET/CT instead of CT alone.

A hospital’s suggestion that a Michigan woman raise $10,000 before being considered for a heart transplant fueled outrage last month, but that situation isn’t all that uncommon, according to a Dec. 5 story from Kaiser Health News.

Prone stereotactic (PS) vacuum-assisted breast biopsy (VABB) has replaced surgical excision for diagnosing findings identified at mammography, but it also has some significant limitations. Does digital breast tomosynthesis (DBT)-guided VABB provide specialists with a better alternative?

A little weight lifting can have a big impact on heart health, even in the absence of aerobic endurance training, according to recent research in Medicine & Science in Sports & Exercise.

Workplace satisfaction among radiologists is propelled more by intrinsic motivators such as purpose and autonomy than extrinsic motivators such as salary and other financial incentives, according to an article published in the Journal of the American College of Radiology.

Moving a motorized wheelchair typically involves operating a joystick or using sensors. That may soon change after Hoobox Robotics, a Brazil-based technology company, teamed up with Intel to create software that uses AI to help the disabled drive motorized wheelchairs with facial expressions, according to a report by USA Today.

Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.

If finalized, the proposed regulations and requirements of the new rule will “provide structure, clarity and transparency” for the De Novo classification process and include processes and criteria for accepting, granting, declining and withdrawing De Novo requests, according to the FDA.